Published in Dis Colon Rectum on April 01, 2005
Modern management of rectal cancer: a 2006 update. World J Gastroenterol (2006) 1.20
Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review. Insights Imaging (2010) 1.11
Current trends in staging rectal cancer. World J Gastroenterol (2011) 1.02
Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol (2011) 1.00
How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy? World J Gastroenterol (2013) 0.95
Utility of magnetic resonance imaging in anorectal disease. World J Gastroenterol (2007) 0.89
Multimodal imaging evaluation in staging of rectal cancer. World J Gastroenterol (2014) 0.85
The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer. Eur J Nucl Med Mol Imaging (2012) 0.85
¹⁸F-FDG PET/CT-based treatment response evaluation in locally advanced rectal cancer: a prospective validation of long-term outcomes. Eur J Nucl Med Mol Imaging (2013) 0.84
MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry. Eur Radiol (2007) 0.83
Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy. Cancers (Basel) (2011) 0.83
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial). BMC Cancer (2014) 0.83
Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis (2012) 0.83
Transanal endoscopic surgery in rectal cancer. World J Gastroenterol (2014) 0.82
Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells. Strahlenther Onkol (2011) 0.82
Simple measurements on diffusion-weighted MR imaging for assessment of complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol (2014) 0.82
PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Ecancermedicalscience (2016) 0.80
Imaging paradigms in assessment of rectal carcinoma: loco-regional and distant staging. Cancer Imaging (2012) 0.80
Multidisciplinary treatment of rectal cancer in 2014: where are we going? World J Gastroenterol (2014) 0.80
Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: Results from a prospective study. Oncol Lett (2015) 0.79
Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Nucl Med Mol Imaging (2014) 0.78
Anatomical considerations in TNM staging and therapeutical procedures for low rectal cancer. Int J Colorectal Dis (2007) 0.76
Optimal imaging staging of rectal cancer. EJC Suppl (2013) 0.75
MRI in local staging of rectal cancer: an update. Diagn Interv Radiol (2014) 0.75
Magnetic resonance imaging for diagnosis and neoadjuvant treatment evaluation in locally advanced rectal cancer: A pictorial review. World J Clin Oncol (2017) 0.75
Gastrointestinal imaging-practical magnetic resonance imaging approach. World J Radiol (2014) 0.75
Magnetic Resonance Imaging Evaluation in Neoadjuvant Therapy of Locally Advanced Rectal Cancer: A Systematic Review. Radiol Oncol (2017) 0.75
The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol (2016) 0.75
Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study. Int J Radiat Oncol Biol Phys (2003) 2.25
MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol (2014) 2.13
Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma. J Surg Oncol (2015) 2.09
Increasing donor body weight to prevent small-for-size syndrome in living donor liver transplantation. World J Surg (2010) 2.06
Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist (2007) 1.85
SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology (2011) 1.67
Pneumothorax after bevacizumab-containing chemotherapy: a case report. Jpn J Clin Oncol (2010) 1.62
Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol (2005) 1.55
Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism. J Cancer Res Clin Oncol (2014) 1.49
Gamma Knife surgery for cerebral arteriovenous malformations in children: a 13-year experience. J Neurosurg Pediatr (2008) 1.48
Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis. Ann Surg Oncol (2011) 1.28
A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys (2002) 1.28
Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology (2013) 1.28
Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology (2011) 1.23
Rectal perforation: a life-threatening complication of stapled hemorrhoidectomy: report of a case. Dis Colon Rectum (2003) 1.23
UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma. Cancer (2008) 1.20
Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Colorectal Dis (2011) 1.17
Expression of beta-F1-ATPase and mitochondrial transcription factor A and the change in mitochondrial DNA content in colorectal cancer: clinical data analysis and evidence from an in vitro study. Int J Colorectal Dis (2008) 1.16
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol (2010) 1.16
Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer (2006) 1.16
Treatment of spinal cord ependymomas by surgery with or without postoperative radiotherapy. J Neurooncol (2005) 1.15
Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: the emerging role for radioembolization using yttrium-90. Oncology (2013) 1.12
Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma. Clin Cancer Res (2007) 1.10
Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres. Int J Radiat Oncol Biol Phys (2010) 1.10
Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer. Int J Colorectal Dis (2011) 1.09
Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis Colon Rectum (2005) 1.08
Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J Surg Res (2005) 1.08
Metastatic potential in T1 and T2 colorectal cancer. Hepatogastroenterology (2005) 1.06
A homologue of the Drosophila headcase protein is a novel tumor marker for early-stage colorectal cancer. Oncol Rep (2006) 1.06
Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. Cancer Sci (2009) 1.04
Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization. Genes Chromosomes Cancer (2005) 1.04
Re-evaluating transarterial chemoembolization for the treatment of hepatocellular carcinoma: Consensus recommendations and review by an International Expert Panel. Liver Int (2013) 1.04
Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum (2008) 1.04
CIP2A is a predictor of poor prognosis in colon cancer. J Gastrointest Surg (2012) 1.03
MR features of abdominal splenosis. AJR Am J Roentgenol (2003) 1.02
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery. Radiat Oncol (2013) 1.02
Surgical resection combined with chemotherapy can help achieve better outcomes in patients with primary colonic lymphoma. J Surg Oncol (2011) 1.01
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC). Liver Int (2013) 1.00
SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer. Ann Surg Oncol (2009) 1.00
Retroperitoneal venous hemangioma. J Formos Med Assoc (2005) 1.00
ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma. Cancer Sci (2009) 1.00
Mitochondrial D-loop mutation is a common event in colorectal cancers with p53 mutations. Int J Colorectal Dis (2009) 1.00
Long-term prognosis of patients with obstructing carcinoma of the right colon. Am J Surg (2004) 0.99
Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Colorectal Dis (2007) 0.99
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. J Surg Oncol (2012) 0.99
Diffuse reflectance spectroscopy detects increased hemoglobin concentration and decreased oxygenation during colon carcinogenesis from normal to malignant tumors. Opt Express (2009) 0.99
Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol (2008) 0.98
CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer. Hepatogastroenterology (2002) 0.98
Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma. World J Gastroenterol (2005) 0.95
Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol (2004) 0.95
Anti-angiogenic effect of silymarin on colon cancer LoVo cell line. J Surg Res (2003) 0.95
Loss of heterozygosity: an independent prognostic factor of colorectal cancer. World J Gastroenterol (2005) 0.94
Differences in clinicopathological characteristics of colorectal cancer between younger and elderly patients: an analysis of 322 patients from a single institution. Am J Surg (2011) 0.94
Surgical resection of duodenal lymphangiectasia: a case report. World J Gastroenterol (2003) 0.92
Retroperitoneal bronchogenic cyst mimicking pancreatic cystic lesion. J Chin Med Assoc (2006) 0.92
Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Liver Transpl (2011) 0.92
The impact of preoperative chemoradiotherapy on advanced low rectal cancer. J Surg Oncol (2010) 0.92
Role of MTHFR polymorphisms and folate levels in different phenotypes of sporadic colorectal cancers. Int J Colorectal Dis (2006) 0.92
Clinical meaning of age-related expression of fecal cytokeratin 19 in colorectal malignancy. BMC Cancer (2009) 0.91
Colon cancer stem cells resist antiangiogenesis therapy-induced apoptosis. Cancer Lett (2012) 0.91
Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Colorectal Dis (2010) 0.91
Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. Med Oncol (2007) 0.91
Association of C-reactive protein gene polymorphisms and colorectal cancer. Ann Surg Oncol (2011) 0.91
Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC). Transl Res (2007) 0.91
Predisposing factors, management, and prognostic evaluation of acute carotid blowout syndrome. J Vasc Surg (2013) 0.91
The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg (2013) 0.90
The unusual presentation of gastric adenocarcinoma as a testicular mass: a favorable response to docetaxel and Cisplatin plus oral tegafur/uracil and leucovorin. J Chin Med Assoc (2010) 0.90
Retained rectal foreign bodies. J Chin Med Assoc (2003) 0.90
Prospective study of the functional results of transanal endoscopic microsurgery. Hepatogastroenterology (2003) 0.90
Oct4-related cytokine effects regulate tumorigenic properties of colorectal cancer cells. Biochem Biophys Res Commun (2011) 0.89